About LipoCoat
LipoCoat is a company based in Enschede (Netherlands) founded in 2016 by Alain Le Loux, Pascal Jonkheijm, and Jasper van Weerd. LipoCoat has raised $1.64 million across 5 funding rounds from investors including Rabobank, European Union and High Tech Fund. LipoCoat offers products and services including Coating Technology and Surface Measurements. LipoCoat operates in a competitive market with competitors including WeInnovate Biosolutions, Endomimetics, Wissenkraft Labs and Solar Sharc, among others.
- Headquarter Enschede, Netherlands
- Founders Alain Le Loux, Pascal Jonkheijm, Jasper van Weerd
-
Sectors
Chemicals & MaterialsTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lipocoat Bv
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.64 M (USD)
in 5 rounds
-
Latest Funding Round
$311.93 K (USD), Grant
Oct 01, 2020
-
Investors
Rabobank
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LipoCoat
LipoCoat offers a comprehensive portfolio of products and services, including Coating Technology and Surface Measurements.
Provides bio-inspired coatings to prevent fouling on medical devices.
Offers analysis of medical device surfaces for fouling properties.
People of LipoCoat
Unlock access to complete
Unlock access to complete
Funding Insights of LipoCoat
LipoCoat has successfully raised a total of $1.64M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $311.93 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LipoCoat
LipoCoat has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Rabobank, European Union and High Tech Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for LipoCoat
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LipoCoat
Investment portfolio details for LipoCoat
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LipoCoat
Detailed financials for LipoCoat
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lipocoat Comparisons
Peer comparison for LipoCoat
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LipoCoat
LipoCoat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WeInnovate Biosolutions, Endomimetics, Wissenkraft Labs and Solar Sharc, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antimicrobial medical devices are provided for infection prevention and control.
|
|
| Locked | Locked | Locked |
Bio-nanometric coatings for medical implants are developed.
|
|
| Locked | Locked | Locked |
Advanced surface coatings for biomedical and engineering uses are provided.
|
|
| Locked | Locked | Locked |
Develops advanced coatings for solar panel protection against contamination and soiling.
|
Detailed competitors of LipoCoat
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lipocoat
Complete news archive for LipoCoat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LipoCoat
LipoCoat was founded in 2016 and raised its 1st funding round 1 year after it was founded.
LipoCoat is headquartered in Enschede, Netherlands. It is registered at Enschede, Overijssel, Netherlands.
Jasper van Weerd is the current CEO of LipoCoat. They have also founded this company.
LipoCoat is a funded company, having raised a total of $1.64M across 5 funding rounds to date.
LipoCoat was founded in 2016 in Enschede, Netherlands, within the biotechnology sector. Hydrophilic coatings inspired by biological systems are developed for medical devices to prevent surface fouling and microbial adhesion. The FAST technology, derived from synthetic chemicals, is utilized in drug-screening processes and industrial operations including drug manufacturing, food processing, and water purification. Operations focus on surface modification solutions for enhanced device performance.
LipoCoat's top competitors include Endomimetics, WeInnovate Biosolutions and Wissenkraft Labs.
LipoCoat offers Coating Technology and Surface Measurements.
LipoCoat has 5 investors. Key investors include Rabobank, European Union, High Tech Fund, Lumana Invest, and EIC Fund.